• ARCA Cy5 EGFP mRNA: A Dual-Readout Benchmark

  2026-09-11

  ARCA Cy5 EGFP mRNA (5-moUTP) separates mRNA uptake from productive protein expression in mammalian cells. This article shows how to use its dual fluorescence design to make delivery-system comparisons more mechanistically informative, drawing on nanoparticle stability research.

• IPR-803: From uPAR Binding to Stromal Remodeling

  2026-09-10

  IPR-803 is a urokinase receptor inhibitor that connects direct uPAR–uPA blockade with invasion, angiogenesis, and pancreatic tumor-stroma research. This guide translates its biochemical, cellular, and nanomedicine evidence into practical assay decisions.

• DHHC9–STRN4 Palmitoylation Drives Cancer Metastasis

  2026-09-10

  This study identifies DHHC9-mediated STRN4 palmitoylation as a regulatory mechanism that activates YAP and promotes adenocarcinoma migration and metastasis. Its combination of genetic, proteomic, functional, and pharmacological evidence positions the DHHC9–STRN4–YAP axis as a promising preclinical framework for investigating palmitoylation-directed cancer therapies.

• Ibotenic Acid for Neural Circuit Models

  2026-09-09

  Ibotenic acid is a practical NMDA receptor agonist for probing excitotoxic circuit disruption, focal neuronal injury, and glutamatergic signaling modulation. This guide connects formulation control with the brain-to-spinal pain circuitry reported in a Cell Reports study, while emphasizing assay controls, interpretation limits, and troubleshooting.

• Biotin-XX Tyramide: From Signal to Spatial Insight

  2026-09-09

  Biotin-XX Tyramide Reagent connects high-sensitivity tyramide signal amplification with membrane-restricted spatial biology. This article examines its mechanism, experimental controls, translational applications, and the practical implications of neurotransmitter interference in HRP-mediated proximity labeling.

• AICAR Phosphate: AMPK Assay Workflows

  2026-09-08

  AICAR phosphate, also known as Acadesine, connects AMPK pathway activation with apoptosis-focused workflows in B-CLL and exploratory mitochondrial studies. This guide combines dose-ranging, caspase and cytochrome c readouts, storage guidance, and a carefully bounded extension to mechanically loaded periodontal models.

• HyperScript RT SuperMix for qPCR: Hypoxia-to-qPCR

  2026-09-08

  HyperScript RT SuperMix for qPCR supports reliable cDNA synthesis from structured or scarce RNA. This article translates recent SQOR–ferroptosis findings in hypoxic pancreatic cancer into practical reverse-transcription and qPCR assay decisions.

• Neuroligin 1, D2-MSNs, and Repetitive Behavior

  2026-09-07

  This Advanced Science study identifies striatal D2 receptor-expressing medium spiny neurons as a cell-type-specific driver of excessive self-grooming and digging after Neuroligin 1 loss. By combining behavioral analysis, neuronal activity manipulation, single-nucleus RNA sequencing, and protein validation, the work connects D2-MSN hyperactivity with PKC overactivation and provides a mechanistic framework for studying restricted and repetitive behaviors.

• Tomivosertib and Human DRG Hyperexcitability

  2026-09-07

  The reference study provides direct human evidence that MNK inhibition can rapidly and reversibly suppress spontaneous activity in cultured dorsal root ganglion neurons obtained from patients with radiculopathy. By pairing electrophysiology with eIF4E Ser209 target-engagement data, it connects MNK-eIF4E signaling to ectopic sensory-neuron activity relevant to neuropathic pain.

• Nilotinib (AMN-107): From BCR-ABL to Translation

  2026-09-05

  A mechanistic and translational framework for using Nilotinib (AMN-107) to interrogate BCR-ABL signaling, kinase-driven cancer models, resistance biology, and carefully bounded neurodegeneration hypotheses.

• CUDC-907: Dual PI3K and HDAC Workflow Guide

  2026-09-04

  CUDC-907 is a dual PI3K and HDAC inhibitor for controlled in vitro studies of PI3K/AKT signaling, histone acetylation, cell-cycle behavior, and apoptosis. This guide covers preparation, controls, readouts, and troubleshooting; the compound is for scientific research only and not for diagnostic, therapeutic, or clinical use.

• Calcitriol Workflows for VDR Research

  2026-09-04

  Calcitriol enables controlled activation of vitamin D receptor signaling in endometrial, immune, bone, and cancer models. This practical guide connects formulation, time-course design, mechanistic validation, and troubleshooting to help researchers distinguish differentiation, cytokine, and proliferation effects.

• S1P/S1PR3 Drives Neuronal Apoptosis After ICH

  2026-09-03

  The reference study identifies S1PR3 as a mediator of neuronal apoptosis after acute intracerebral hemorrhage and connects receptor activation with CCL2, TNF-α, PI3K/AKT, and caspase-3 signaling. Its mouse and HT22-cell experiments suggest that pharmacological S1PR3 inhibition may reduce secondary neuronal injury, while also defining important limitations for translation beyond the tested models.

• BFH772 (VEGFR2 inhibitor) Workflow Guide

  2026-09-03

  BFH772 is a selective small-molecule VEGFR2 inhibitor for controlled studies of receptor-driven angiogenesis, including endothelial and tumor angiogenesis models. Its water insolubility and defined kinase selectivity make it unsuitable for aqueous stock preparation, broad-spectrum kinase screening, or experiments requiring an established in vivo dosing regimen without additional optimization.

• Cyclopamine: Hedgehog Signaling Inhibitor Workflows

  2026-09-02

  Cyclopamine is a Smoothened-targeting Hedgehog signaling inhibitor for connecting pathway blockade with proliferation, apoptosis, invasion, and developmental phenotypes. This practical guide covers dose design, breast and colorectal cancer workflows, teratogenicity studies in animal models, and troubleshooting strategies that separate on-target biology from formulation or assay artifacts.

7732 records 2/516 page Previous Next 12345 下5页 Last page